Riskpilot← Back to searchSign inGet full accessDRUGMODE ApS
APSDissolvedCVR 29600937Agern Alle 24-26Forskning og eksperimentel udvikling indenfor bioteknologi · NACE 721100Est. 2006— employees
Revenue 2014
DKK -494K
-53% vs 2013
EBITDA margin
100.0%
+53% vs 2013
Equity ratio
-52059.2%
Financial strength
Net profit 2014
DKK -4,1M
+9% vs 2013
| Revenue | DKK -494K | -53% |
| EBITDA | DKK -494K | +53% |
| Net profit | DKK -4,1M | +9% |
| Total assets | DKK 145K | -33% |
| Equity | DKK -75,6M | -6% |
| Employees | — | — |
Legal name
DRUGMODE ApS
CVR number
29600937
Legal form
Anpartsselskab
NACE code
721100 · Forskning og eksperimentel udvikling indenfor bioteknologi
Founded
24. maj 2006
Share capital
DKK 18.781.001
Employees
—
VAT registered
No
Audit selected
No
Last report
2014-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsens formand og en direktør i forening samt af den samlede bestyrelse.
Address
Agern Alle 24-26
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 |
|---|---|---|---|
| Revenue | -2.492 | -1.048 | -494 |
| Staff expenses | -0 | -0 | -0 |
| EBITDA | -2.492 | -1.048 | -494 |
| Depreciation & amort. | -0 | -0 | -0 |
| EBIT | -2.492 | -1.048 | -494 |
| Net financials | -3.135 | -3.447 | -3.654 |
| Profit before tax | -5.628 | -4.496 | -4.148 |
| Tax | -191 | 84 | -0 |
| Net profit | -5.436 | -4.580 | -4.148 |
| Item | 2012 | 2013 | 2014 |
|---|---|---|---|
| Total assets | 432 | 217 | 145 |
| Equity | -66.858 | -71.438 | -75.587 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 67.291 | 71.656 | 75.732 |
| Total debt | 67.291 | 71.656 | 75.732 |
EBITDA margin
-49429800.0%
This company
15.8%
Market median
-312846935% vs market
20122014
Equity ratio
-52059.2%
This company
38.2%
Market median
-136381% vs market
20122014
Return on equity
-414835200.0%
This company
18.4%
Market median
-2254539230% vs market
20122014
Net profit margin
-414835200.0%
This company
8.1%
Market median
-5121422322% vs market
20122014
Asset turnover
-3.40×
This company
1.12×
Market median
-404% vs market
20122014
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20122014
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MP Management | Management | 2011 | — | — |
SJ Management | Management | 2007 | — | — |
PM Management | Management | 2006 | — | — |
AM Management | Management | 2006 | — | — |
SS Management | Management | 2006 | — | — |
JR Management | Management | 2011 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2007 | — | — | |
| Chairman | 2006 | — | — | |
| Board of Directors | 2008 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
FEY HOLDING ApS | Company | 5.0% | 5.0% | 2011 |
MC2 Therapeutics A/S | Company | 90.0% | 90.0% | 2011 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DRUGMODE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Morten Præstegaard | Management | 0 companies |
| Stephen John Fey | Management | 0 companies |
| Peter Mose Larsen | Management | 0 companies |
| Anette Merete Nøhr Clausen | Management | 0 companies |
| Steen Sindet-Pedersen | Management | 0 companies |
| Jesper Roested | Management | 0 companies |
| Jørgen Marcus Nøhr Clausen | Board of Directors | 0 companies |
| Jesper Jørn Lange | Chairman | 0 companies |
| Mads Jørgen Nøhr Clausen | Board of Directors | 0 companies |